Home > Insider Trading > Filing (0001214659-23-016008)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1138723	Accuray Inc	ARAY	Surgical & Medical Instruments & Apparatus (3841)	208370041

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1927592	Sandeep Chalke	1310 Chesapeake Terrace Sunnyvale CA 94089	Svp, Chief Commercial Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-11-30	150,943	$0.00	570,225	No	4	A	Direct
Common Stock	Disposition	2023-12-01	14,585	$2.47	555,640	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

This represents a Restricted Stock Unit grant with a grant date of 11/30/2023 that vest annually over three years from grant date.
Includes 2,500 shares acquired on May 31, 2023 and 2,500 shares acquired on November 30, 2023 under the Accuray Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c).
Adjusted to remove shares related to Performance Stock Unit grants erroneously reported on Table I on December 7, 2022.
Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.4707 to $2.4835, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.